Skip to content

ProLung, Inc.: 10-Q filed 2022-08-15

What ProLung, Inc. reported in its quarterly report filed 2022-08-15 (fiscal Q2 2022): 29 published measures, 83 facts as tagged in accession 0001493152-22-022841.

This filing

Form
10-Q (quarterly report)
Filed
2022-08-15
Fiscal period
fiscal Q2 2022
Accession
0001493152-22-022841 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ProLung, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-06-301,390,681USD
At 2021-12-31884,115USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-06-3012,987,599USD
At 2021-12-3112,435,011USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-06-30-11,596,918USD
At 2022-03-31-11,383,200USD
At 2021-12-31-11,550,896USD
At 2021-06-30-10,069,548USD
At 2021-03-31-9,434,013USD
At 2020-12-31-8,845,138USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2022-06-301,270,287USD
At 2021-12-31745,003USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-911,600USD91
2022-01-01 to 2022-06-30-2,673,024USD181
2022-01-01 to 2022-03-31-1,761,424USD90
2021-04-01 to 2021-06-30-872,213USD91
2021-01-01 to 2021-06-30-1,597,762USD181
2021-01-01 to 2021-03-31-725,549USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-1,296,394USD181
2021-01-01 to 2021-06-30-971,481USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-06-303,904USD181
2021-01-01 to 2021-06-302,137USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-06-301,825,582USD181
2021-01-01 to 2021-06-302,361,409USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-3,904USD181
2021-01-01 to 2021-06-30-2,137USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-06-30-42,799,783USD
At 2021-12-31-40,126,759USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-04-01 to 2022-06-304,610,149shares91
2022-01-01 to 2022-06-304,384,905shares181
2021-04-01 to 2021-06-304,104,785shares91
2021-01-01 to 2021-06-304,096,618shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-0.2USD/shares91
2022-01-01 to 2022-06-30-0.61USD/shares181
2021-04-01 to 2021-06-30-0.21USD/shares91
2021-01-01 to 2021-06-30-0.39USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-06-307,246USD
At 2021-12-3121,183USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-04-01 to 2022-06-30191,022USD91
2022-01-01 to 2022-06-30801,420USD181
2021-04-01 to 2021-06-30144,173USD91
2021-01-01 to 2021-06-30194,976USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-705,032USD91
2022-01-01 to 2022-06-30-2,135,553USD181
2021-04-01 to 2021-06-30-670,299USD91
2021-01-01 to 2021-06-30-1,139,685USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-06-301,270,287USD
At 2021-12-31745,003USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2022-04-01 to 2022-06-30206,568USD91
2022-01-01 to 2022-06-30537,471USD181
2021-04-01 to 2021-06-30336,053USD91
2021-01-01 to 2021-06-30592,216USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-06-302,530,577USD
At 2021-12-3112,435,011USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-06-3029,128USD
At 2021-12-3113,733USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2022-06-30113,148USD
At 2021-12-31117,929USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-04-01 to 2022-06-30705,032USD91
2022-01-01 to 2022-06-302,135,553USD181
2021-04-01 to 2021-06-30670,299USD91
2021-01-01 to 2021-06-301,139,685USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2022-04-01 to 2022-06-30472,673USD91
2022-01-01 to 2022-06-301,176,483USD181
2021-04-01 to 2021-06-30456,244USD91
2021-01-01 to 2021-06-30746,321USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-04-01 to 2022-06-30232,359USD91
2022-01-01 to 2022-06-30959,070USD181
2021-04-01 to 2021-06-30214,055USD91
2021-01-01 to 2021-06-30393,364USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-06-304,610,149shares
At 2021-12-314,122,130shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-06-3031,360,756USD
At 2021-12-3128,571,741USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-06-302,186,449USD
At 2021-12-311,775,849USD

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-206,568USD91
2022-01-01 to 2022-06-30-537,471USD181
2021-04-01 to 2021-06-30-201,914USD91
2021-01-01 to 2021-06-30-458,077USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-06-3030,504USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-3015,395USD181
2021-01-01 to 2021-06-30-32,524USD181

Inspect the source

Entity
ProLung, Inc. / CIK 0001541884
Captured
SEC response SHA-256
26fae87b912f65fc5ab9df3ab6d4cc8d691238e302986003cfa05f4773424079

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001541884.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))